BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 2663504)

  • 1. Rational pharmacotherapy of gastrointestinal motility disorders.
    Demol P; Ruoff HJ; Weihrauch TR
    Eur J Pediatr; 1989 Apr; 148(6):489-95. PubMed ID: 2663504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal receptors and drugs in motility disorders.
    Ruoff HJ; Fladung B; Demol P; Weihrauch TR
    Digestion; 1991; 48(1):1-17. PubMed ID: 1651261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prokinetic agents for lower gastrointestinal motility disorders.
    Longo WE; Vernava AM
    Dis Colon Rectum; 1993 Jul; 36(7):696-708. PubMed ID: 8348856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs coordinating and restoring gastrointestinal motility and their effect on selected hypodynamic gastrointestinal disorders in horses and cattle.
    Steiner A; Roussel AJ
    Zentralbl Veterinarmed A; 1995 Dec; 42(10):613-31. PubMed ID: 8822186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prokinetic drugs].
    Hellström P
    Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.
    Wiseman LR; Faulds D
    Drugs; 1994 Jan; 47(1):116-52. PubMed ID: 7510617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medicamentous modification of gastrointestinal motility and secretion].
    Allescher HD
    Z Gastroenterol; 1991 Apr; 29 Suppl 3():27-30. PubMed ID: 1648290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)].
    Jovanović-Mićić D; Janković S; Beleslin DB
    Srp Arh Celok Lek; 1994; 122(1-2):50-4. PubMed ID: 17972806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gastrointestinal motility disorders and drugs: opioids, calcium antagonists, nitrates, peptides, prostaglandins and 5-hydroxytryptaminergic drugs (part II)].
    Jovanović-Mićić D; Samardzić R; Beleslin B
    Srp Arh Celok Lek; 1994; 122(3-4):88-92. PubMed ID: 17972818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status of gastric prokinetic drugs.
    Schapira M; Henrion J; Heller FR
    Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domperidone: a peripherally acting dopamine2-receptor antagonist.
    Barone JA
    Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
    Scarpignato C; Pelosini I
    Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifiers of gastrointestinal motility of cattle.
    Steiner A
    Vet Clin North Am Food Anim Pract; 2003 Nov; 19(3):647-60. PubMed ID: 14608805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.
    McCallum RW; Prakash C; Campoli-Richards DM; Goa KL
    Drugs; 1988 Dec; 36(6):652-81. PubMed ID: 3065057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.
    Tack J; Coremans G; Janssens J
    Drug Saf; 1995 Jun; 12(6):384-92. PubMed ID: 8527013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.
    Tonini M; De Giorgio R; De Ponti F
    Drugs; 2004; 64(4):347-61. PubMed ID: 14969571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prokinetic agents.
    Reynolds JC; Putnam PE
    Gastroenterol Clin North Am; 1992 Sep; 21(3):567-96. PubMed ID: 1516959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial cells of Cajal as targets for pharmacological intervention in gastrointestinal motor disorders.
    Huizinga JD; Thuneberg L; Vanderwinden JM; Rumessen JJ
    Trends Pharmacol Sci; 1997 Oct; 18(10):393-403. PubMed ID: 9357324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of prokinetic drugs for treatment of postoperative ileus in the horse.
    Dart AJ; Hodgson DR
    Aust Vet J; 1998 Jan; 76(1):25-31. PubMed ID: 9578763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prokinetics and fundic relaxants in upper functional GI disorders.
    Tack J
    Curr Opin Pharmacol; 2008 Dec; 8(6):690-6. PubMed ID: 18940266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.